Form 4 for EHC Encompass Health Corp
Accepted 2026-02-20 00:00:00 ET · period of report 2026-02-18 · accession 0000785161-26-000039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-02-20 | 2026-02-18+ | EHC | Tarr Mark J | Pres, CEO, Dir | A - Grant | $0.00 | +113.7K | 478.0K | +31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Encompass Health Common Stock | 2026-02-19 | A | A | 12,796 | $0.00 | 490,812 | D | — | — | (F2) Annual award of restricted stock pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan. |
| 2 | Common | Encompass Health Common Stock | 2026-02-18 | A | A | 100,946 | $0.00 | 478,016 | D | — | — | (F1) This issuance of restricted stock is the result of the satisfaction of performance criteria set out in the terms of a performance share unit award made on February 23, 2023. |